摘要 |
<p>The present invention relates to the use of an inducible genetic recombination system to target expression of a toxin to cancer cells and to hereby prevent the recurrence of particular tumors. The present invention also relates to the use of an inducible genetic recombination system to target expression of diphtheria toxin to androgen-independent cancer cells following androgen ablation therapy and to thereby prevent the development of recurrent prostatic tumors.</p> |